aFraxis Lands $1,200,000 New Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=eec0d63a-734f-4d62-8530-9b01f23fd002&Preview=1 -
Date
5/16/2010 -
Company Name
aFraxis -
Mailing Address
5626 Oberlin Dr. San Diego, CA 92121 -
Company Description
Afraxis is discovering and developing drugs to treat diseases of the central nervous system, including schizophrenia, Alzheimer’s disease, Fragile X syndrome and autism spectrum disorders. Recent scientific discoveries have linked these disorders to underlying defects in the development and function of specialized structures of the neural synapse, called dendritic spines. -
Website
http://www.Afraxis.com -
Transaction Type
Venture Equity -
Transaction Amount
$1,200,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Undisclosed
